Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
A 14-year-old girl with type 1 diabetes mellitus (T1DM) attends your clinic, following a negative TTG IgA at her 3-yearly coeliac disease (CD) screening. You reflect on the value of one-off HLA typing for CD in diabetic children, to avoid this 3 yearly test. You believe that the negative predictive value in those children without risk-HLA haplotypes associated with CD (HLA DQ2 or 8) is near to 100%, and therefore they would not need further TTG screening for CD. However, you wonder if there would be a significant number of patients with T1DM who are HLA DQ2 or DQ8 negative, which would make HLA typing unreliable as a screening test.
Structured clinical question
In a child with T1DM where CD screening is already in place (patient), would one-off HLA typing for CD (intervention) remove the need for 3 yearly TTG IgA/endomysial antibodies (EMA) blood testing? (outcome). …
Competing interests None declared.
Provenance and peer review Not commissioned; internally peer reviewed.